Abstract
BackgroundFalls are common undesirable events for older adults in institutions. Even though the patient’s fall risk may be scored on admission, the medication-induced fall risk may be ignored. This study developed a preliminary categorization of fall-risk-increasing drugs (FRIDs) to be added as a risk factor to the existing fall risk assessment tool routinely used in geriatric care units.MethodsMedication use data of older adults who had experienced at least one fall during a hospital ward or a nursing home stay within a 2-year study period were retrospectively collected from patient records. Medicines used were classified into three risk categories (high, moderate and none) according to the fall risk information in statutory summaries of product characteristics (SmPCs). The fall risk categorization incorporated the relative frequency of such adverse drug effects (ADEs) in SmPCs that were known to be connected to fall risk (sedation, orthostatic hypotension, syncope, dizziness, drowsiness, changes in blood pressure or impaired balance). Also, distribution of fall risk scores assessed on admission without considering medications was counted.ResultsThe fall-experienced patients (n = 188, 128 from the hospital and 60 from nursing home records) used altogether 1748 medicaments, including 216 different active substances. Of the active substances, 102 (47%) were categorized as high risk (category A) for increasing fall risk. Fall-experienced patients (n = 188) received a mean of 3.8 category A medicines (n = 710), 53% (n = 375) of which affected the nervous and 40% (n = 281) the cardiovascular system. Without considering medication-related fall risk, 53% (n = 100) of the patients were scored having a high fall risk (3 or 4 risk scores).ConclusionIt was possible to develop a preliminary categorization of FRIDs basing on their adverse drug effect profile in SmPCs and frequency of use in older patients who had experienced at least one documented fall in a geriatric care unit. Even though more than half of the fall-experienced study participants had high fall risk scores on admission, their fall risk might have been underestimated as use of high fall risk medicines was common, even concomitant use. Further studies are needed to develop the FRID categorization and assess its impact on fall risk.
Highlights
Falls are common undesirable events for older adults in institutions
This study aimed to provide a better screen on falls in institutions by developing a preliminary categorization of fall-risk-increasing drugs (FRIDs) that could be added as a risk factor to the existing fall risk assessment tool routinely used in geriatric care units
The half (52%) of the patients had at least a mild cognitive impairment (≤ 23 points), the mean score in the Mini Mental State Exam (MMSE) being 21.7 points
Summary
Falls are common undesirable events for older adults in institutions. Even though the patient’s fall risk may be scored on admission, the medication-induced fall risk may be ignored. This study developed a preliminary categorization of fall-risk-increasing drugs (FRIDs) to be added as a risk factor to the existing fall risk assessment tool routinely used in geriatric care units. Intrinsic factors are related to ageing, including age-related changes to the pharmacokinetic and pharmacodynamic effects of pharmacotherapies. Age-related pharmacokinetic changes are represented by drug absorption, distribution, metabolism and elimination route. The drug distribution is affected by many factors, e.g., increase in fat compartment, decrease in total body water, muscle mass and serum albumin level. The distribution volume of water soluble drugs is decreased leading to their potential toxicity, while the distribution volume of lipid soluble drugs is increased leading to prolongation of elimination half-life and accumulation of the drug in fatty tissues. Pharmacodynamic changes involve altered sensitivity to many pharmacological agents, increased sensitivity in psychotropic or cardiovascular drugs, in contrast with decreased capacity to respond to physiological challenges and side effects of the drug therapy, e.g., orthostatic hypotension [1, 9]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.